# Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States

> **NCT00143026** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 184 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** carbidopa, levodopa, entacapone

## Key facts

- **NCT ID:** NCT00143026
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2017-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00143026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00143026, "Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00143026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*